elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34617294-96D94F85-5811-48F7-AECB-0ED3D69F9150
Q34617294-96D94F85-5811-48F7-AECB-0ED3D69F9150
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34617294-96D94F85-5811-48F7-AECB-0ED3D69F9150
NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use
P2860
Q34617294-96D94F85-5811-48F7-AECB-0ED3D69F9150
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34617294-96D94F85-5811-48F7-AECB-0ED3D69F9150
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc2d0d7195ff7e081ab4a454dd0668a7cd4967ba
P2860
Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor.